Shoshana Shendelman

All filings by Shoshana Shendelman on record concern Applied Therapeutics Inc., in the capacity of chief executive. Between 13 September 2021 and 5 August 2024, the trades on record add up to 14 filings.

Market trades split into 4 purchases (€104k) and 5 sales (€2.1M). The net balance comes to €2.0M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 4 share grants. Since January 2024: no purchases and 2 sales on the market.

The median purchase comes to €27k. No cluster: in 4 purchases, no other insider of the company bought within 30 days.

Most recently, on 14 August 2024, the filings show a transaction in Applied Therapeutics Inc. The last purchase on record was published on 14 October 2022, which is 1,465 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.